These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30892297)

  • 1. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
    Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
    Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
    Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
    Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of smart stimuli-responsive mesoporous organosilica nano-vehicles for targeted pesticide delivery.
    Liang Y; Gao Y; Wang W; Dong H; Tang R; Yang J; Niu J; Zhou Z; Jiang N; Cao Y
    J Hazard Mater; 2020 May; 389():122075. PubMed ID: 31972522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
    Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells.
    Giménez C; de la Torre C; Gorbe M; Aznar E; Sancenón F; Murguía JR; Martínez-Máñez R; Marcos MD; Amorós P
    Langmuir; 2015 Mar; 31(12):3753-62. PubMed ID: 25742160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-responsive nanocarrier based on heparin end-capped mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo.
    Dai L; Li J; Zhang B; Liu J; Luo Z; Cai K
    Langmuir; 2014 Jul; 30(26):7867-77. PubMed ID: 24933090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
    Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of biodegradable Mn-doped mesoporous silica nanoparticles for pH/redox dual response drug delivery.
    Li X; Zhang X; Zhao Y; Sun L
    J Inorg Biochem; 2020 Jan; 202():110887. PubMed ID: 31670257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.
    Lin JT; Liu ZK; Zhu QL; Rong XH; Liang CL; Wang J; Ma D; Sun J; Wang GH
    Colloids Surf B Biointerfaces; 2017 Jul; 155():41-50. PubMed ID: 28407530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
    Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
    Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
    Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
    ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.